Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100042044Phase 4Recruiting
Phase 4, randomised trial of remimazolam in esophageal varices (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Wake up time. Started Jan 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100042044.